NCT05818215

Brief Summary

A retrospective cohort study to explore the impact of the FIFA World Cup 2022 Qatar on paediatric emergency department attendance at two tertiary centres during unprecedent winter viral epidemics.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 5, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 18, 2023

Completed
Last Updated

April 18, 2023

Status Verified

April 1, 2023

Enrollment Period

1.4 years

First QC Date

April 5, 2023

Last Update Submit

April 5, 2023

Conditions

EmergenciesEpidemic DiseasePediatric ALLElectronic Medical Record

Keywords

Pediatric Emergency MedicineEmergency Service HospitalPediatricsEpidemicsRespiratory Syncytial VirusesInfluenza, HumanSARS-CoV-2Sports

Outcome Measures

Primary Outcomes (1)

  • PED visits

    Retrospective analysis of number of PED visits (counts).

    Institutional electronic medical records analysed retrospectively from October 1st, 2022 to December 31, 2022

Secondary Outcomes (7)

  • Triage acuity score

    Institutional electronic medical records analysed retrospectively from October 1st, 2022 to December 31, 2022

  • Chief complaint

    Institutional electronic medical records analysed retrospectively from October 1st, 2022 to December 31, 2022

  • Main diagnosis

    Institutional electronic medical records analysed retrospectively from October 1st, 2022 to December 31, 2022

  • Audience

    Analysed retrospectively from October 1st, 2022 to December 31, 2022

  • RSV incidence

    Analysed retrospectively from October 1st, 2022 to December 31, 2022

  • +2 more secondary outcomes

Study Arms (1)

All participants

Data from electronic medical records of all patients under 16 years of age with medical, surgical and traumatology emergencies attending the paediatric emergency departments during the study period

Other: NO intervention

Interventions

NO interventionOTHER

NO intervention

All participants

Eligibility Criteria

AgeUp to 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

All patients under 16 years of age with medical, surgical and traumatology emergencies attending each pediatric emergency department during the study period will be included. This also includes transfer cases from other hospitals, as well as those who leave prematurely without being seen.

You may qualify if:

  • all patients

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Geneva Children's Hospital

Geneva, Switzerland

Location

MeSH Terms

Conditions

EmergenciesPrecursor Cell Lymphoblastic Leukemia-LymphomaInfluenza, Human

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsLeukemia, LymphoidLeukemiaNeoplasms by Histologic TypeNeoplasmsHematologic DiseasesHemic and Lymphatic DiseasesLymphoproliferative DisordersLymphatic DiseasesImmunoproliferative DisordersImmune System DiseasesRespiratory Tract InfectionsInfectionsOrthomyxoviridae InfectionsRNA Virus InfectionsVirus DiseasesRespiratory Tract Diseases

Study Officials

  • Johan N Siebert, MD

    Geneva Children's Hospital, Geneva University Hospitals, Geneva, Switzerland

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 5, 2023

First Posted

April 18, 2023

Study Start

September 1, 2021

Primary Completion

January 20, 2023

Study Completion

January 20, 2023

Last Updated

April 18, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will share

Individual Participant Data will be deidentified and the study investigators will house the data locally on secured servers at the Geneva University Hospitals. The datasets used or analysed during the current trial will be available from the corresponding author upon reasonable request. Only deidentified/anonymised data will be shared.

Time Frame
Available from 6 month to 5 years after trial publication.
Access Criteria
* Data will be made available from the corresponding author upon approval of a proposal and with a signed data access agreement. * Data will be made available for a specified research purpose. * The request proposal must include a statistician.

Locations

CH(1)